APRIL MURRIETA: Open Payments
NPI 1265995237 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 27 payments from 17 companies in 2025. Trend: 2023 $346 · 2024 $158 · 2025 $682
Food & beverage: $666Entertainment: $15
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $186 |
| Janssen Pharmaceuticals, Inc | 2 | $68 |
| Exact Sciences Corporation | 2 | $51 |
| Novo Nordisk Inc | 2 | $47 |
| Lilly USA, LLC | 2 | $45 |
| Inspire Medical Systems, Inc. | 1 | $42 |
| SpringWorks Therapeutics, Inc. | 1 | $33 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: QULIPTA, SPRAVATO, The Cologuard Plus Collection Kit, MOUNJARO, INSPIRE, GOMEKLI, ZORYVE, Ozempic.
Industry payments across TX — which companies pay providers there.
